Blurred Lines: Marketing and Ethics in the Brave New World, Part 2
// By Daniel Fell //
The following article is Part 2 of a 2-part series. (Read Part 1 here). The series was adapted from the panel presentation Blurred Lines: Marketing and Ethics in the Brave New World held at the 2018 Healthcare Internet Conference (HCIC) in Scottsdale, Arizona. Panel members include Karen Corrigan, founder and CEO of Corrigan Consulting; David Feinberg, chief marketing officer at Mount Sinai Health System in New York City; and Greg Green, chief data and analytics officer of Valassis.
Daniel Fell, president and CEO of ndp, moderated the panel. Part 1 touched on some of the broad ethical issues in using digital marketing in healthcare today and some of the current practices in our industry. Part 2 addresses some of the emerging challenges as both technology and our industry evolve, and what marketers can do to better prepare themselves and their organizations.
FELL: The lines between hospital, insurance company, and retail setting are beginning to blur with new mergers between pharmacy chains and insurance companies and tech giants like Amazon getting into healthcare. How does that impact the way we use data?
This content is only available to members.
Please log in.
Not a member yet?
Start a free 7-day trial membership to get instant access.
Log in below to access this content: